why choose us

First received: December 14, 2022

Clinical Trial: LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Recurrent Glioblastoma

Study Type: Interventional


Official Title: Safety and Efficacy of LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas

Brief Summary: This study aims to investigate the safety and efficacy of Laser Interstitial Thermal Therapy (LITT) combined with postoperative early use of temozolomide in treating recurrent glioblastomas.

Read more